Cite
MLA Citation
Yago Nieto et al.. “High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan.” Lancet, vol. 4, no. 6, 2017, pp. e283–e292. http://access.bl.uk/ark:/81055/vdc_100046742829.0x00001e